The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Kidney Injury Molecule-1 and its association with delayed clearance and drug exposure in pediatric oncology patients treated with high dose methotrexate.
 
Andrew J. Bukowinski
No Relationships to Disclose
 
Tomoyuki Mizuno
No Relationships to Disclose
 
Tsuyoshi Fukuda
No Relationships to Disclose
 
A.a. Vinks
Honoraria - Horizon Pharma
Consulting or Advisory Role - Pfizer (Inst); TEVA (Inst)
Patents, Royalties, Other Intellectual Property - AssureX - a health company that markets a pharmacogenetic test for neuropsychiatric drugs
 
Stuart Goldstein
Stock and Other Ownership Interests - HemaCare
Honoraria - Baxter; Gambro
Consulting or Advisory Role - Bard Medical; Baxter; Baxter; Gambro; Gambro; La Jolla Pharma; Otsuka
Speakers' Bureau - Baxter; Gambro
Research Funding - Baxter; Gambro
 
Adam Lane
No Relationships to Disclose
 
John Peter Perentesis
No Relationships to Disclose
 
Maureen Megan O'Brien
Research Funding - Amgen (Inst); Epizyme (Inst); Novartis (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene